EUVIMEDEUVIMED entdecken
Crossref

Effect of Cumulative Exposure to Ocrelizumab on Memory B‐Cell Repopulation Dynamics in Multiple Sclerosis

Giulio Disanto iD, Rosaria Sacco, Giulia Mallucci, Chiara Zecca, Claudio Gobbi

Annals of Neurology · 2025

DOI: 10.1002/ana.27281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2025. Verfasst von Giulio Disanto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Multiple Sclerosis Center, Department of Neurology, Neurocenter of Southern Switzerland (NSI), Regional Hospital of Lugano, Ente Ospedaliero Cantonal…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Memory B Cells, Multiple Sclerosis, Immunologic Factors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Swiss MS Society, AFRI (Area Formazione Accademica, Ricerca e Innovazione), Ente Ospedaliero Cantonale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Extended interval dosing protocols of B‐cell‐depleting therapies in multiple sclerosis (MS) are being developed, but intervals between infusions are often arbitrary. We describe total and memory B‐cell repopulation dynamics in MS patients on a memory B‐cell‐guided extended interval dosing ocrelizumab (OCR) protocol.

Methods

OCR was administered on peripheral CD19+ CD27+ memory B‐cell repopulation (≥1 cell/μL), monitored using fluorescence‐activated cell sorting. Associations with CD19+ B cells and CD19+ CD27+ memory B cells were tested using mixed‐effect hurdle models, with rate ratios (RR) predicting cell counts and odds ratios (OR) predicting cell depletion.

Results

We collected 1,369 samples from 101 patients, 61.4% women, aged 42.2 years (IQR 32.3–51.1 years) and follow up 4.1 years (IQR 2.9–5.2 years). The median time between samples and previous OCR infusion was 6.6 months (IQR 4.7–8.8 months). Time since previous OCR infusion was positively associated with CD19+ B cells (RR = 1.11, 95% CI 1.10–1.11, p < 0.001) and CD19+ CD27+ memory B‐cell counts (RR = 1.11, 95% CI 1.09–1.13, p < 0.001). A greater cumulative OCR dose was associated with persistent CD19+ CD27+ memory B‐cell depletion (OR 1.90, 1.57–2.31, p < 0.001). CD19+ B‐cell repopulation was inversely associated with age (RR = 0.82, 95% CI 0.71–0.95, p = 0.010). Female patients showed a lower ratio of CD19+ CD27+ memory B cells/total CD19+ B cells (RR = 0.42, 95% CI 0.26–0.69, p = 0.001). Disease activity was low, with most radiological activity observed within the first year of OCR treatment.

Interpretation

Memory B‐cell repopulation becomes slower with increasing cumulative OCR dose. Age‐ and sex‐related mechanisms probably influence repopulation dynamics. Given the evidence for a pathogenic role of memory B cells, these observations could be considered when planning extended interval dosing strategies of OCR treatment. ANN NEUROL 2025;98:603–615

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedMemory B CellsMultiple SclerosisImmunologic FactorsB-LymphocytesHumansFemaleAdultMaleMiddle AgedAntigens, CD19

Substanzen

ocrelizumabAntibodies, Monoclonal, HumanizedImmunologic FactorsAntigens, CD19

Autor:innen und Institutionen

  • Multiple Sclerosis Center, Department of Neurology, Neurocenter of Southern Switzerland (NSI), Regional Hospital of Lugano, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Faculty of Biomedical Sciences, University of Italian Switzerland (USI), Lugano, Switzerland.

ORCID-Profile: Giulio Disanto

Förderung

  • Swiss MS Society
  • AFRI (Area Formazione Accademica, Ricerca e Innovazione), Ente Ospedaliero Cantonale

Zitieren

APA

Disanto, G., Sacco, R., Mallucci, G., Zecca, C., & Gobbi, C. (2025). Effect of Cumulative Exposure to Ocrelizumab on Memory B‐Cell Repopulation Dynamics in Multiple Sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.27281

Vancouver

Disanto G, Sacco R, Mallucci G, Zecca C, Gobbi C. Effect of Cumulative Exposure to Ocrelizumab on Memory B‐Cell Repopulation Dynamics in Multiple Sclerosis. Annals of Neurology. 2025. doi:10.1002/ana.27281

BibTeX
@article{Disanto2025,
  author = {Disanto, Giulio and Sacco, Rosaria and Mallucci, Giulia and Zecca, Chiara and Gobbi, Claudio},
  title = {Effect of Cumulative Exposure to Ocrelizumab on Memory B‐Cell Repopulation Dynamics in Multiple Sclerosis},
  journal = {Annals of Neurology},
  year = {2025},
  doi = {10.1002/ana.27281}
}
Kostenlos starten →